Home / Business and Economy / Staar Surgical's $50M Buyback Sparks Investor Interest
Staar Surgical's $50M Buyback Sparks Investor Interest
26 Sep
Summary
- Staar Surgical authorized a significant $50 million stock buyback program.
- The company's shares rose over 7% following the announcement.
- Management cited strong confidence and undervaluation as reasons for the repurchase.
Staar Surgical's stock experienced a notable increase, finishing Friday more than 7% higher after the eyecare specialist announced a substantial share buyback program. The company's board of directors has authorized the repurchase of up to $50 million of its common stock.
This initiative is set to occur in the open market over approximately one year, reflecting management's confidence in Staar's business trajectory and financial strength. CEO Warren Foust stated that the buyback underscores the company's belief that its stock is significantly undervalued.
Staar's recent financial performance supports this decision, with second-quarter net sales more than doubling year-over-year, driven by strong growth in its primary market, China. The company also achieved profitability and maintained a strong cash position of nearly $149 million.
